Cargando…

Anti-Inflammatory Effects of Statins Beyond Cholesterol Lowering

Detalles Bibliográficos
Autor principal:	Joo, Seung-Jae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467441/ https://www.ncbi.nlm.nih.gov/pubmed/23091502 http://dx.doi.org/10.4070/kcj.2012.42.9.592

Ejemplares similares

Beyond lipid lowering: pleiotropic effects of statins in heart failure
por: Swenne, C. A.
Publicado: (2013)

Statins suppress cell-to-cell propagation of α-synuclein by lowering cholesterol
por: Min, Joo-Ok, et al.
Publicado: (2023)

Anti-inflammatory effects of perioperative statin therapy
por: van Klei, Wilton A., et al.
Publicado: (2012)

Racial Differences in the Cholesterol-Lowering Effect of Statin
por: Naito, Ryo, et al.
Publicado: (2017)

Pre-Treatment with Statins for Coronary Intervention: Pleiotropy of Statins or Effect of LDL-cholesterol Reduction?
por: Habon, Tamas, et al.
Publicado: (2016)

Influence of Previous Statin Therapy on Cholesterol-Lowering Effect of Ezetimibe
por: Choi, Young Hwan, et al.
Publicado: (2014)

Therapeutic implications of statins beyond lipid lowering: In the perspective of their effects on the antigen presentation, T cells and NKT cells
por: Khan, Masood Alam
Publicado: (2021)

RHOA Is a Modulator of the Cholesterol-Lowering Effects of Statin
por: Medina, Marisa W., et al.
Publicado: (2012)

Correction: RHOA Is a Modulator of the Cholesterol-Lowering Effects of Statin
por: Medina, Marisa W., et al.
Publicado: (2013)

Of statins and low-density lipoprotein cholesterol, “fats” and fiction
por: Unnikrishnan, Ambika Gopalakrishnan, et al.
Publicado: (2016)

Forecasting Cholesterol Management-End of the Statin Gold Rush?
por: Crownover, Brian K., et al.
Publicado: (2006)

Statins redux: A re-assessment of how statins lower plasma cholesterol
por: Raghow, Rajendra
Publicado: (2017)

Diet in Stroke: Beyond Antiplatelets and Statins
por: James, Joe
Publicado: (2019)

Potent anti-ischaemic effects of statins in chronic stable angina: incremental benefit beyond lipid lowering?
por: Deanfield, John E., et al.
Publicado: (2010)

Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer
por: Morofuji, Yoichi, et al.
Publicado: (2022)

Are statins anti-inflammatory?
por: Blake, Gavin J, et al.
Publicado: (2000)

Can Statin Prevent the Risk of Colorectal Cancer in Patients with Inflammatory Bowel Disease?
por: Jang, Hyun Joo
Publicado: (2019)

Cholesterol suppresses antimicrobial effect of statins
por: Haeri, Mohammad Reza, et al.
Publicado: (2015)

Are Patients with Low Non-HDL Cholesterol “Non-responders” to Statin Therapy on Coronary Plaque Regression?
por: Koba, Shinji
Publicado: (2016)

Should We Intensify Statin Management in ACS Patients with Very Low LDL Cholesterol Levels?
por: Han, Ki Hoon
Publicado: (2019)

Cholesterol lowering for secondary prevention: What statin dose should we use?
por: Josan, Kiranbir, et al.
Publicado: (2007)

Astragalus Polysaccharides Lowers Plasma Cholesterol through Mechanisms Distinct from Statins
por: Cheng, Yunjiu, et al.
Publicado: (2011)

Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
por: Bardolia, Chandni, et al.
Publicado: (2021)

Cholesterol lowering: to live longer, start younger?
por: Wang, Nelson, et al.
Publicado: (2020)

Effect of a PCSK9 inhibitor and a statin on cholesterol efflux capacity: A limitation of current cholesterol‐lowering treatments?
por: Ying, Qidi, et al.
Publicado: (2022)

High LDL cholesterol and statin use were independently associated with lower eight-year mortality in a cohort free from terminal illness, cardiovascular disease, and diabetes at baseline
por: Thulesius, Hans
Publicado: (2014)

Cholesterol, Statins, and Alzheimer Disease
por: Koudinov, Alexei R, et al.
Publicado: (2005)

Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012)

Beyond LDL-Cholesterol: The Role of Low HDL-Cholesterol and Elevated TG in Residual Cardiovascular Risk Remaining After Statin Therapy
por: Watson, Karol E.
Publicado: (2008)

Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma
por: Yi, Sang-Wook, et al.
Publicado: (2019)

Statins Lower Lipid Synthesis But Promote Secretion of Cholesterol-Enriched Extracellular Vesicles and Particles
por: Chen, Yundi, et al.
Publicado: (2022)

Genetically Guided Statin Therapy on Statin Perceptions, Adherence, and Cholesterol Lowering: A Pilot Implementation Study in Primary Care Patients
por: Li, Josephine H., et al.
Publicado: (2014)

Evaluation of anti-inflammatory effect of statins in chronic periodontitis
por: Suresh, Snophia, et al.
Publicado: (2013)

A chicken protein hydrolysate exerts anti‐atherosclerotic effect beyond plasma cholesterol‐lowering activity in Apoe(−/−) mice
por: Bjørndal, Bodil, et al.
Publicado: (2019)

New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
por: Kim, Kyuho, et al.
Publicado: (2022)

New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
por: Kim, Kyuho, et al.
Publicado: (2022)

Statin Intolerance and Suboptimal Statin Therapy
por: Tada, Hayato, et al.
Publicado: (2019)

Anti-VEGF and Beyond
por: Bertelmann, T., et al.
Publicado: (2017)

290 The Correlation of Cholesterol Lowering Statin Drugs and Worsening Asthma Control in Mild Persistent Asthmatics
por: Nsouli, Safa
Publicado: (2012)

Evaluating the Cost-Effectiveness of Statins
por: Hay, Joel W.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_18jest8l0k1g6is1phpu6he3rt